|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM156318288 |
| 003 |
DE-627 |
| 005 |
20231223073921.0 |
| 007 |
tu |
| 008 |
231223s2005 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0521.xml
|
| 035 |
|
|
|a (DE-627)NLM156318288
|
| 035 |
|
|
|a (NLM)15993649
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Kim, Ho
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages
|
| 264 |
|
1 |
|c 2005
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 28.09.2005
|
| 500 |
|
|
|a Date Revised 08.04.2022
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a ErratumIn: Clin Immunol. 2006 May;119(2):227
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Cyclophilin A (CypA) levels increase in the sera and synovial fluids of rheumatoid arthritis (RA) patients, but the cell types expressing CypA and the function of CypA in the pathogenesis of RA are not known yet. Immunohistochemistry analyses revealed high level CypA staining in the macrophages in the lining layers of human RA and osteoarthritis synovium. Low level CypA staining was also detected in endothelial cells, lymphocytes, and smooth muscle cells in RA synovium. Further investigation of the CypA function using monocyte/macrophage cell lines revealed that CypA induced expression of cytokine/chemokines such as TNF-alpha, IL-8, MCP-1, and IL-1beta and matrix metalloproteinase (MMP)-9 through a pathway that is dependent on NFkappaB activation. Furthermore, MMP-9 staining pattern overlapped with that of CypA in both RA and OA synovium. Our data suggest that CypA may stimulate macrophages to degrade joint cartilage via MMP-9 expression and promote inflammation via pro-inflammatory cytokine secretion
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
7 |
|a Cytokines
|2 NLM
|
| 650 |
|
7 |
|a Inflammation Mediators
|2 NLM
|
| 650 |
|
7 |
|a Matrix Metalloproteinase 9
|2 NLM
|
| 650 |
|
7 |
|a EC 3.4.24.35
|2 NLM
|
| 650 |
|
7 |
|a Cyclophilin A
|2 NLM
|
| 650 |
|
7 |
|a EC 5.2.1.-
|2 NLM
|
| 700 |
1 |
|
|a Kim, Won-Jung
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Jeon, Sung-Tak
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Koh, Eun-Mi
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Cha, Hoon-Suk
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ahn, Kwang-Sung
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Lee, Won-Ha
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 116(2005), 3 vom: 01. Sept., Seite 217-24
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:116
|g year:2005
|g number:3
|g day:01
|g month:09
|g pages:217-24
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 116
|j 2005
|e 3
|b 01
|c 09
|h 217-24
|